Cargando…

Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy

PURPOSE: Matrix metalloproteinase-14 (MMP-14) is a transmembrane MMP that plays a critical role in promoting angiogenesis. We investigated the expression levels of MMP-14 and correlated the levels with clinical disease activity and with the levels of the angiogenic factors vascular endothelial growt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abu El-Asrar, Ahmed M., Mohammad, Ghulam, Allegaert, Eef, Ahmad, Ajmal, Siddiquei, Mohammad Mairaj, Alam, Kaiser, Gikandi, Priscilla W., De Hertogh, Gert, Opdenakker, Ghislain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Vision 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5957543/ https://www.ncbi.nlm.nih.gov/pubmed/29853773

Ejemplares similares

Differential Expression and Localization of ADAMTS Proteinases in Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2022)

CD146/Soluble CD146 Pathway Is a Novel Biomarker of Angiogenesis and Inflammation in Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2021)

The Proinflammatory and Proangiogenic Macrophage Migration Inhibitory Factor Is a Potential Regulator in Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2019)

CD40 Ligand–CD40 Interaction Is an Intermediary between Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2023)

Evaluation of Proteoforms of the Transmembrane Chemokines CXCL16 and CX3CL1, Their Receptors, and Their Processing Metalloproteinases ADAM10 and ADAM17 in Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2021)

Relationship between Vitreous Levels of Matrix Metalloproteinases and Vascular Endothelial Growth Factor in Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Coexpression of heparanase activity, cathepsin L, tissue factor, tissue factor pathway inhibitor, and MMP-9 in proliferative diabetic retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2016)

Neurotrophins and Neurotrophin Receptors in Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Expression of bioactive lysophospholipids and processing enzymes in the vitreous from patients with proliferative diabetic retinopathy
por: Abu El-Asrar, Ahmed M, et al.
Publicado: (2014)

S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2014)

Macrophage-Myofibroblast Transition Contributes to Myofibroblast Formation in Proliferative Vitreoretinal Disorders
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2023)

Tissue Inhibitor of Metalloproteinase-3 Ameliorates Diabetes-Induced Retinal Inflammation
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2022)

Association of HMGB1 with oxidative stress markers and regulators in PDR
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2017)

Angiogenic and Vasculogenic Factors in the Vitreous from Patients with Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Poly (ADP-Ribose) Polymerase Mediates Diabetes-Induced Retinal Neuropathy
por: Mohammad, Ghulam, et al.
Publicado: (2013)

High-Mobility Group Box-1 and Endothelial Cell Angiogenic Markers in the Vitreous from Patients with Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2012)

The ERK(1/2) Inhibitor U0126 Attenuates Diabetes-Induced Upregulation of MMP-9 and Biomarkers of Inflammation in the Retina
por: Mohammad, Ghulam, et al.
Publicado: (2013)

Osteopontin and Other Regulators of Angiogenesis and Fibrogenesis in the Vitreous from Patients with Proliferative Vitreoretinal Disorders
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2012)

The Proinflammatory Cytokine High-Mobility Group Box-1 Mediates Retinal Neuropathy Induced by Diabetes
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2014)

High-Mobility Group Box-1 Induces Decreased Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in the Diabetic Retina
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Soluble cytokine receptor levels in aqueous humour of patients with specific autoimmune uveitic entities: sCD30 is a biomarker of granulomatous uveitis
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2019)

Endothelial-to-mesenchymal transition contributes to the myofibroblast population in proliferative diabetic retinopathy
por: Abu El-Asrar, Ahmed M.
Publicado: (2016)

Matrix Metalloproteinase-2 in the Development of Diabetic Retinopathy and Mitochondrial Dysfunction
por: Mohammad, Ghulam, et al.
Publicado: (2010)

Therapeutic Interventions against Inflammatory and Angiogenic Mediators in Proliferative Diabetic Retinopathy
por: Gologorsky, Daniel, et al.
Publicado: (2012)

How to place the duality of specific MMP-9 inhibition for treatment of inflammatory bowel diseases into clinical opportunities?
por: Opdenakker, Ghislain, et al.
Publicado: (2022)

New Developments in the Pathophysiology and Management of Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Angiogenic Potential of Vitreous from Proliferative Diabetic Retinopathy and Eales' Disease Patients
por: Murugeswari, Ponnalagu, et al.
Publicado: (2014)

High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy
por: El-Asrar, Ahmed M. Abu, et al.
Publicado: (2011)

Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy
por: Jee, Kathleen, et al.
Publicado: (2017)

Targeting proliferative retinopathy: Arginase 1 limits vitreoretinal neovascularization and promotes angiogenic repair
por: Fouda, Abdelrahman Y., et al.
Publicado: (2022)

Thymocyte development in the absence of matrix metalloproteinase-9/gelatinase B
por: Gounko, Natalia V., et al.
Publicado: (2016)

Correlations Between Different Angiogenic and Inflammatory Factors in Vitreous Fluid of Eyes With Proliferative Diabetic Retinopathy
por: Wu, Guanrong, et al.
Publicado: (2021)

New Perspectives on the Immunopathogenesis and Treatment of Uveitis Associated With Vogt-Koyanagi-Harada Disease
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2021)

Oxidative Stress, Inflammatory, Angiogenic, and Apoptotic molecules in Proliferative Diabetic Retinopathy and Diabetic Macular Edema Patients
por: Andrés-Blasco, Irene, et al.
Publicado: (2023)

Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy
por: Beránek, Michal, et al.
Publicado: (2008)

Vitreous Hemorrhage in Pediatric Age Group
por: AlHarkan, Dora H., et al.
Publicado: (2014)

Expression of stem cell factor/c-kit signaling pathway components in diabetic fibrovascular epiretinal membranes
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2010)

Proliferative diabetic retinopathy transcriptomes reveal angiogenesis, anti-angiogenic therapy escape mechanisms, fibrosis and lymphatic involvement
por: Korhonen, Ani, et al.
Publicado: (2021)

Vitreous inflammatory and angiogenic factors on patients with proliferative diabetic retinopathy or diabetic macular edema: the role of Lipocalin2
por: Batsos, Georgios, et al.
Publicado: (2022)

Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
por: Babapoor-Farrokhran, Savalan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_h4okr66mvnfaj72igjdpubof2o